The technology for MSI detection with deep learning was developed in at RWTH University Hospital Aachen, Aachen, Germany. Jakob Nikolas Kather, Amelie Echle, Tom Luedde, Christian Trautwein, Peter Boor, Lara Heij and Nadine Gaisa are part of the project site Aachen. More information on our deep learning technology is available at http://www.kather.ai
A number of partner sites in the MSIDETECT consortium is contributing additional pathology expertise, epidemiology expertise and additional patient samples:
Samples from the DACHS study coordinated by Michael Hoffmeister, Hermann Brenner and Jenny Chang-Claude at the German Cancer Research Center, Heidelberg, Germany have been analyzed within our consortium.
From the University Hospital Maastricht, Maastricht, The Netherlands, Heike Grabsch and Piet van den Brandt contribute expertise in Histopathology and Epidemiology.
Philip Quirke, Nicholas West and Susan Richman from the University of Leeds, Leeds, United Kingdom are experts in colorectal cancer and key partners in MSIDETECT.
Alexander T. Pearson from the Department of Hematology/Oncology at University of Chicago Medicine, Chicago, IL, USA contributes clinical and technology expertise to the consortium.